S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
pixel
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
pixel
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
pixel
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
pixel
Log in
NYSE:HRC

Hill-Rom Stock Forecast, Price & News

$101.90
+0.74 (+0.73 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$99.81
Now: $101.90
$102.92
50-Day Range
$94.09
MA: $98.72
$103.84
52-Week Range
$72.29
Now: $101.90
$117.68
Volume296,730 shs
Average Volume427,315 shs
Market Capitalization$6.76 billion
P/E Ratio30.69
Dividend Yield0.87%
Beta0.58
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising non-invasive devices that provide respiratory support and assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include tables, lights, and pendants; and positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. It sells and rents products to acute and extended care facilities through direct sales force and distributors; sells and rents products directly to patients in the home; and sells products to primary care facilities through distributors. Hill-Rom Holdings, Inc. was founded in 1915 and is headquartered in Chicago, Illinois.
Hill-Rom logo

MarketRank

Overall MarketRank

2.03 out of 5 stars

Medical Sector

48th out of 1,925 stocks

Surgical & Medical Instruments Industry

8th out of 169 stocks

Analyst Opinion: 2.4Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP43147510
Phone312-819-7200
Employees10,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.88 billion
Cash Flow$10.26 per share
Book Value$25.92 per share

Profitability

Net Income$223 million

Miscellaneous

Market Cap$6.76 billion
Next Earnings Date2/5/2021 (Confirmed)
OptionableOptionable
$101.90
+0.74 (+0.73 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Hill-Rom (NYSE:HRC) Frequently Asked Questions

How has Hill-Rom's stock price been impacted by COVID-19 (Coronavirus)?

Hill-Rom's stock was trading at $89.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HRC shares have increased by 14.3% and is now trading at $101.90.
View which stocks have been most impacted by COVID-19
.

Is Hill-Rom a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Hill-Rom stock.
View analyst ratings for Hill-Rom
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Hill-Rom?

Wall Street analysts have given Hill-Rom a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Hill-Rom wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is John P. Groetelaars' approval rating as Hill-Rom's CEO?

54 employees have rated Hill-Rom CEO John P. Groetelaars on Glassdoor.com. John P. Groetelaars has an approval rating of 82% among Hill-Rom's employees.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, February 5th 2021.
View our earnings forecast for Hill-Rom
.

How can I listen to Hill-Rom's earnings call?

Hill-Rom will be holding an earnings conference call on Friday, February 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) issued its earnings results on Friday, November, 6th. The medical technology company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.10. The medical technology company earned $705.30 million during the quarter, compared to analyst estimates of $696.36 million. Hill-Rom had a trailing twelve-month return on equity of 22.71% and a net margin of 7.74%. Hill-Rom's revenue for the quarter was down 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.69 earnings per share.
View Hill-Rom's earnings history
.

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom announced a quarterly dividend on Wednesday, November 4th. Shareholders of record on Wednesday, December 16th will be paid a dividend of $0.22 per share on Thursday, December 31st. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date is Tuesday, December 15th.
View Hill-Rom's dividend history
.

Is Hill-Rom a good dividend stock?

Hill-Rom pays an annual dividend of $0.88 per share and currently has a dividend yield of 0.87%. The dividend payout ratio of Hill-Rom is 15.91%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Hill-Rom will have a dividend payout ratio of 14.31% next year. This indicates that Hill-Rom will be able to sustain or increase its dividend.
View Hill-Rom's dividend history.

What guidance has Hill-Rom issued on next quarter's earnings?

Hill-Rom updated its FY21 earnings guidance on Friday, November, 6th. The company provided earnings per share guidance of $5.25-5.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.38.

What price target have analysts set for HRC?

7 brokers have issued 12 month price objectives for Hill-Rom's shares. Their forecasts range from $107.00 to $125.00. On average, they expect Hill-Rom's share price to reach $118.43 in the next year. This suggests a possible upside of 16.2% from the stock's current price.
View analysts' price targets for Hill-Rom
or view Wall Street analyst' top-rated stocks.

Are investors shorting Hill-Rom?

Hill-Rom saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 541,800 shares, a drop of 27.5% from the December 15th total of 747,800 shares. Based on an average daily trading volume, of 495,300 shares, the short-interest ratio is presently 1.1 days. Currently, 0.8% of the company's stock are sold short.
View Hill-Rom's Short Interest
.

Who are some of Hill-Rom's key competitors?

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), The Walt Disney (DIS), NVIDIA (NVDA), Square (SQ), PayPal (PYPL), salesforce.com (CRM), CVS Health (CVS), Micron Technology (MU), AbbVie (ABBV) and Bank of America (BAC).

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • Mr. John P. Groetelaars, Pres, CEO & Director (Age 53, Pay $2.23M)
  • Ms. Barbara W. Bodem, Sr. VP & CFO (Age 52, Pay $1.13M)
  • Ms. Deborah M. Rasin, Sr. VP, Chief Legal Officer & Sec. (Age 53, Pay $906.56k)
  • Mr. Andreas G. Frank, Sr. VP & Pres of Front Line Care business (Age 44, Pay $1.12M)
  • Mr. Paul S. Johnson, Sr. VP & Pres of Patient Support Systems (Age 55, Pay $981.63k)
  • Mr. Timothy P. Lawrence, Sr. VP of Operations (Age 57)
  • Mr. Richard M. Wagner, VP, Controller & CAO (Age 52)
  • Mr. Brian Lawrence, CTO & Sr. VP (Age 50)
  • Ms. Sue-Jean Lin, Chief Information Officer & Sr. VP
  • Ms. Mary Kay Ladone, Sr. VP of Corp. Devel., Strategy & Investor Relations (Age 45)

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

Who are Hill-Rom's major shareholders?

Hill-Rom's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (0.96%), Mountain Pacific Investment Advisers Inc. ID (0.40%), Candriam Luxembourg S.C.A. (0.27%), Retirement Systems of Alabama (0.24%), New York State Teachers Retirement System (0.13%) and Nisa Investment Advisors LLC (0.07%). Company insiders that own Hill-Rom stock include Amy M Dodrill, Andreas G Frank, Deborah Rasin, Mary Kay Ladone and Paul Sherwood Johnson.
View institutional ownership trends for Hill-Rom
.

Which major investors are selling Hill-Rom stock?

HRC stock was sold by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., Pacer Advisors Inc., New York State Teachers Retirement System, Wedge Capital Management L L P NC, Private Trust Co. NA, State of Alaska Department of Revenue, Crossmark Global Holdings Inc., and OLD National Bancorp IN. Company insiders that have sold Hill-Rom company stock in the last year include Amy M Dodrill, Andreas G Frank, Mary Kay Ladone, and Paul Sherwood Johnson.
View insider buying and selling activity for Hill-Rom
or view top insider-selling stocks.

Which major investors are buying Hill-Rom stock?

HRC stock was bought by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Mountain Pacific Investment Advisers Inc. ID, Charles Schwab Trust Co, IBM Retirement Fund, Landsberg Bennett & Dubbaneh LLC, Nisa Investment Advisors LLC, Signature Estate & Investment Advisors LLC, and Deroy & Devereaux Private Investment Counsel Inc..
View insider buying and selling activity for Hill-Rom
or or view top insider-buying stocks.

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $101.90.

How big of a company is Hill-Rom?

Hill-Rom has a market capitalization of $6.76 billion and generates $2.88 billion in revenue each year. The medical technology company earns $223 million in net income (profit) each year or $5.53 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.